[1]Barnett R. Acute myocardial infarction[J]. Lancet, 2019, 393:2580.doi:10.1016/s0140(19)31419-9. [2]Gao M, Qin L, Zhang Z, et al. Treatment windows and clinical outcomes in late-presenting patients with ST-segment elevation myocardial infarction[J]. Am J Med Sci, 2019, 358:248-255. [3]王梓豪, 贺继刚, 谢巧丽,等. 过表达GATA-4的小鼠骨髓间充质干细胞改善小鼠心肌梗死后的心功能[J]. 基础医学与临床, 2019, 39:1229-1233. [4]张丹, 贾小凤. 参麦注射液辅助治疗急性心肌梗死的临床研究[J]. 中西医结合心脑血管病杂志, 2019, 17:1890-1894. [5]赵传艳, 王昕. 制备心肌梗死大鼠模型方法的改进[J]. 中国组织工程研究, 2014, 18:2886-2891. [6]何海娟, 杨燕青, 戴勤学. 腺苷A1受体介导参麦注射液对肢体缺血再灌注损伤大鼠海马组织的保护作用[J]. 中国中医急症, 2018, 27:1321-1324. [7]Badae NM, El Naggar AS, El Sayed SM. Is the cardioprotective effect of the ACE2 activator diminazene aceturate more potent than the ACE inhibitor enalapril on acute myocardial infarction in rats[J]. Can J Physiol Pharmacol, 2019, 97:638-646. [8]Tea V, Danchin N, Puymirat E. Myocardial infarction in young patient: epidemiological specificities and risk factors[J]. Presse Med, 2019, 48:1383-1386. [9]Wu Z, Zhao X, Miyamoto A, et al. Effects of steroidal saponins extract from ophiopogon japonicus root ameliorates doxorubicin-induced chronic heart failure by inhibiting oxidative stress and inflammatory response[J]. Pharm Biol, 2019, 57:176-183. [10]施洋, 候宝林, 樊登峰, 等. 参麦注射液对急性心肌梗死大鼠心肌纤维化的干预作用研究[J]. 中国医院药学杂志, 2019, 39:1253-1258. [11]Jiang T, Zhang L, Ding M, et al. Protective effect of vasicine against myocardial infarction in rats via modulation of oxidative stress, inflammation, and the PI3K/AKT pathway[J]. Drug Des Devel Ther, 2019, 13:3773-3784. |